Drugs@FDA document
VENCLEXTA Review · NDA 208573 SUPPL-21
Drugs@FDA document · ABBVIE · Dec 9, 2020
Key facts
| Drug name | VENCLEXTA |
|---|---|
| Document type | Review |
| Application | NDA208573 |
| Submission | SUPPL-21 |
| Company | ABBVIE |
| Document date | Dec 9, 2020 |
At a glance
- Efficacy-Accelerated Approval Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: